Reporter Nov 4 2016
Nov. 3, 2016—In his State of the Medical Center address on Wednesday, Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center (VUMC), and Dean of the Vanderbilt University School of Medicine, described a “Strategic Compass” to help the Medical Center continue to “grow and shine” in the years to come.
Nov. 3, 2016—When Kelly Davis woke up one morning in April, she told her husband Anthony that she dreamed her face was moving; then she looked in the mirror and saw that it really was.
Nov. 3, 2016—Pseudomonas aeruginosa and Staphylococcus aureus — two pathogens that frequently co-infect the lungs of patients with cystic fibrosis — appear to cooperate with each other, Vanderbilt investigators have discovered. When pseudomonas is starved for metal by the host, it shuts down the production of factors that would normally kill staph, promoting a co-infection.
Nov. 3, 2016—Combination therapy using two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response. In a study led by Vanderbilt University Medical Center (VUMC) investigators and published in the Nov. 3 issue of the New England Journal of Medicine, researchers describe two cases of...
Nov. 3, 2016—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
Nov. 3, 2016—Specific interactions between inflammatory cells and epithelial cells contribute to lung fibrosis, according to a study published last week in JCI Insight fromVanderbilt’s Lisa Young, M.D., associate professor of Pediatrics and Medicine and Cell and Developmental Biology, and colleagues.